Skip to main content

Optimizing Breast Cancer Management

  • Book
  • © 2018

Overview

  • Focuses on recent data that influence surgical techniques, radiation therapy techniques, and medical therapeutics
  • Discusses new insights into genetic and lifestyle risks for breast cancer and risk reduction strategies
  • Addresses survivor issues including fertility, sexuality, exercise, and diet

Part of the book series: Cancer Treatment and Research (CTAR, volume 173)

This is a preview of subscription content, log in via an institution to check access.

Access this book

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

eBook USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

About this book

This book presents expert opinions on a variety of key topics related to the management of breast cancer, with a focus on the implications of recent advances and research findings for clinical practice. It also explores the controversy regarding mammography screening and reviews the contribution of new imaging modalities. Considerable attention is paid to developments in surgical procedures, including the potential for the safe and effective use of sentinel lymph node dissection alone—even in patients with positive nodes—and to the advantages and contraindications of new radiotherapy techniques. Genetic aspects are discussed in detail, including an assessment of the role of genetic testing and the potential impact of genetic signatures on breast cancer management. New systemic strategies, such as anti-HER2 therapy, endocrine agents, and agents to reverse endocrine resistance, are considered, and the optimal use of chemotherapy for early-stage and advanced-stage disease is addressed. Inclosing, the book shares important new insights into lifestyle risk factors, risk reduction strategies, and survivor issues, including sexual dysfunction and fertility maintenance.

Similar content being viewed by others

Keywords

Table of contents (11 chapters)

Editors and Affiliations

  • Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, USA

    William J. Gradishar

Bibliographic Information

  • Book Title: Optimizing Breast Cancer Management

  • Editors: William J. Gradishar

  • Series Title: Cancer Treatment and Research

  • DOI: https://doi.org/10.1007/978-3-319-70197-4

  • Publisher: Springer Cham

  • eBook Packages: Medicine, Medicine (R0)

  • Copyright Information: Springer International Publishing AG 2018

  • Hardcover ISBN: 978-3-319-70195-0Published: 26 January 2018

  • Softcover ISBN: 978-3-319-88901-6Published: 04 June 2019

  • eBook ISBN: 978-3-319-70197-4Published: 19 January 2018

  • Series ISSN: 0927-3042

  • Series E-ISSN: 2509-8497

  • Edition Number: 1

  • Number of Pages: V, 189

  • Number of Illustrations: 11 illustrations in colour

  • Topics: Oncology, Gynecology, Radiotherapy

Publish with us